For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.

Dexamethasone was given orally at 20 mg on days 1, 8, 15 ... single-arm, phase 2 trial" Lancet Haematol 2025; DOI: 10.1016/S2352-3026(24)00347-8.

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

The glucocorticoid dexamethasone (Dex ... on neonatal day 1 (0.5 mg/kg body weight), day 2 (0.3 mg/kg) and day 3 (0.1 mg/kg) or with equal volumes (10 mL/kg) of sterile pyrogen free saline ...

In clinical practice, dexamethasone tapering schedules are often prescribed for short-term therapy, and usually consists of an empiric reduction in dose of 2-4 mg every 1-3 days, by either ...

Failure to suppress cortisol levels below 50 nmol/l after low dose dexamethasone (0.5 mg every 6 h for eight doses ending at 0300 h, or 1 mg at 2300 h with serum cortisol measured the following ...

In addition, Scilex has three product candidates: (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel ... of acute pain and for which Scilex has recently completed a Phase 2 trial in acute ...

A doctor may recommend a course of oral steroids to treat a flare-up and for 1 or 2 weeks following IV treatment ... increased appetite and weight gain. Dexamethasone can be administered orally ...

2 Department of Rheumatology ... with arthralgia positive for ACPA or IgM-RF were randomly allocated to intramuscular injections of 100 mg dexamethasone or placebo at baseline and 6 weeks. The primary ...